Medical Disclaimer: These calculators may contain errors and are for reference only — always reconfirm results with a qualified physician before clinical use.
kg

How the dose is calculated

Piperacillin-tazobactam is dosed by its piperacillin component in mg/kg/day; the tazobactam component (a beta-lactamase inhibitor) follows automatically at the product's fixed 8:1 ratio. This is an injectable (IV) antibiotic — no suspension volume conversion applies.

Typical dosing by indication

IndicationDoseFrequencyMax
Standard240 mg/kg/day (pip.)every 8h (3×/day)12000 mg/day
Severe/pseudomonal300 mg/kg/day (pip.)every 6h (4×/day)16000 mg/day

All doses above refer to the piperacillin component only — the tazobactam dose follows automatically at the fixed 8:1 ratio. This is a reconstituted IV product; follow your local pharmacy's infusion protocol (including extended-infusion protocols sometimes used for severe/pseudomonal infection) for the actual administration details.

Clinical use

Frequently asked questions

What is piperacillin-tazobactam used for?

It's a broad-spectrum antibiotic combination commonly used for hospital-acquired infections, febrile neutropenia, intra-abdominal infections, and other serious infections where Pseudomonas aeruginosa or mixed/resistant organisms are a concern.

Why is piperacillin-tazobactam dosed by the piperacillin component?

Piperacillin is the component that drives the antibacterial dose needed for the infection, while tazobactam (a beta-lactamase inhibitor) is fixed by the product's ratio and follows automatically.

What does the tazobactam part do?

Tazobactam is a beta-lactamase inhibitor — it blocks the enzyme some bacteria use to destroy piperacillin, restoring piperacillin's effectiveness against those resistant organisms.

Why are extended infusions sometimes used?

For severe or pseudomonal infections, giving the same total dose over a longer infusion time can keep drug concentrations above the target threshold for more of the dosing interval, which may improve outcomes — this follows local pharmacy infusion protocols rather than changing the total daily dose.

References

  1. Freifeld AG, et al. Clinical Practice Guideline for Antimicrobial Prophylaxis and Empiric Therapy in Febrile Neutropenia (IDSA). Clin Infect Dis. 2011.
  2. British National Formulary for Children (BNFc) — Piperacillin/tazobactam.
  3. Solomkin JS, et al. Diagnosis and Management of Complicated Intra-Abdominal Infection (IDSA/SIS). Clin Infect Dis. 2010.

Related calculators

⚠️ For qualified healthcare professionals. Weight-based estimate only — verify against local antibiotic guidelines, the product insert, and the patient's renal/hepatic function and allergy history before prescribing.

← Back to Antibiotics